Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors as of March 31, 2022

Portfolio Holdings for Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors holds 17 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kymera Therapeutics Common Stock (KYMR) 36.8 $291M 6.9M 42.32
Dyne Therapeutics Common Stock (DYN) 10.9 $86M 8.9M 9.64
Day One Biopharmaceuticals Common Stock (DAWN) 10.3 $81M 8.2M 9.92
Generation Bio Common Stock (GBIO) 7.7 $61M 8.3M 7.34
Aerovate Therapeutics Common Stock (AVTE) 7.2 $57M 3.1M 18.33
Replimune Group Common Stock (REPL) 6.9 $55M 3.2M 16.98
Vigil Neuroscience Common Stock (VIGL) 5.2 $41M 5.8M 7.03
Akero Therapeutics Common Stock (AKRO) 4.0 $32M 2.2M 14.19
Ikena Oncology Common Stock (IKNA) 3.9 $31M 5.0M 6.10
Xilio Therapeutics Common Stock (XLO) 2.5 $20M 2.8M 7.07
Magenta Therapeutics Common Stock 1.3 $10M 3.5M 2.90
Spero Therapeutics Common Stock (SPRO) 1.1 $9.0M 1.0M 8.70
Gemini Therapeutics Common Stock 0.9 $7.3M 5.3M 1.39
AvroBio Common Stock (AVRO) 0.8 $6.0M 4.5M 1.32
F-star Therapeutics Common Stock 0.3 $2.1M 600k 3.55
Viridian Therapeutics Common Stock (VRDN) 0.2 $1.7M 90k 18.49
Cogent Biosciences Common Stock (COGT) 0.2 $1.4M 187k 7.49